These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 16413692
1. Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features. Aslan G, Irer B, Tuna B, Yorukoglu K, Saatcioglu F, Celebi I. Pathol Res Pract; 2006; 202(2):93-8. PubMed ID: 16413692 [Abstract] [Full Text] [Related]
2. Increased expression of NKX3.1 in benign prostatic hyperplasia. Irer B, Toylu A, Aslan G, Celebi I, Yorukoglu K, Atabey N. Urology; 2009 May; 73(5):1140-4. PubMed ID: 18597829 [Abstract] [Full Text] [Related]
3. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G, Gasser TC, Koivisto P, Lack EE, Kononen J, Kallioniemi OP, Gelmann EP. Cancer Res; 2000 Nov 01; 60(21):6111-5. PubMed ID: 11085535 [Abstract] [Full Text] [Related]
8. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate. Zhigang Z, Wenlu S. Prostate; 2008 Feb 01; 68(2):190-9. PubMed ID: 18076024 [Abstract] [Full Text] [Related]
10. Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study. Erbersdobler A, Isbarn H, Steiner I, Schlomm T, Chun F, Mirlacher M, Sauter G. Urology; 2009 Nov 01; 74(5):1169-73. PubMed ID: 19476978 [Abstract] [Full Text] [Related]
12. Expression of clusterin in prostate cancer correlates with Gleason score but not with prognosis in patients undergoing radical prostatectomy without neoadjuvant hormonal therapy. Miyake H, Muramaki M, Kurahashi T, Yamanaka K, Hara I, Gleave M, Fujisawa M. Urology; 2006 Sep 01; 68(3):609-14. PubMed ID: 16979705 [Abstract] [Full Text] [Related]
13. Elevated serum progastrin-releasing peptide (31-98) in metastatic and androgen-independent prostate cancer patients. Yashi M, Muraishi O, Kobayashi Y, Tokue A, Nanjo H. Prostate; 2002 May 01; 51(2):84-97. PubMed ID: 11948963 [Abstract] [Full Text] [Related]
15. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer. Takayama H, Nonomura N, Nishimura K, Oka D, Shiba M, Nakai Y, Nakayama M, Tsujimura A, Aozasa K, Okuyama A. BJU Int; 2009 Feb 01; 103(4):470-4. PubMed ID: 18778349 [Abstract] [Full Text] [Related]
16. Expression of major heat shock proteins in prostate cancer: correlation with clinicopathological outcomes in patients undergoing radical prostatectomy. Kurahashi T, Miyake H, Hara I, Fujisawa M. J Urol; 2007 Feb 01; 177(2):757-61. PubMed ID: 17222676 [Abstract] [Full Text] [Related]
17. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer. Thomas C, Wiesner C, Melchior SW, Schmidt F, Gillitzer R, Thüroff JW, Pfitzenmaier J. BJU Int; 2009 Jul 01; 104(1):29-34. PubMed ID: 19154451 [Abstract] [Full Text] [Related]
18. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer]. Yang GS, Wang YM, Chen ZD. Zhonghua Nan Ke Xue; 2006 Feb 01; 12(2):137-40, 144. PubMed ID: 16519150 [Abstract] [Full Text] [Related]